(0.17%) 5 230.37 points
(0.10%) 39 470 points
(0.43%) 16 458 points
(-1.31%) $78.08
(0.08%) $2.38
(0.63%) $2 357.70
(0.97%) $28.72
(2.76%) $1 038.65
(-0.28%) $0.924
(0.04%) $10.81
(-0.21%) $0.795
(-0.23%) $91.38
Quarter results tomorrow
(bmo 2024-05-15)
Expected move: +/- 4.11%
0.06% INR 1 765.50
Live Chart Being Loaded With Signals
Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others...
Stats | |
---|---|
Today's Volume | 83 843.00 |
Average Volume | 498 695 |
Market Cap | 290.80B |
EPS | INR11.65 ( 2024-02-14 ) |
Next earnings date | ( INR13.32 ) 2024-05-15 |
Last Dividend | INR0 ( N/A ) |
Next Dividend | INR0 ( N/A ) |
P/E | 44.13 |
ATR14 | INR0.654 (0.04%) |
Volume Correlation
Gland Pharma Limited Correlation
10 Most Positive Correlations | |
---|---|
PIDILITIND.NS | 0.939 |
AARTIIND.NS | 0.936 |
PAGEIND.NS | 0.935 |
BRFL.NS | 0.934 |
ATUL.NS | 0.933 |
DEVYANI.NS | 0.932 |
MSUMI.NS | 0.926 |
MCDOWELL-N.NS | 0.922 |
RAJMET.NS | 0.918 |
PIXTRANS.NS | 0.917 |
10 Most Negative Correlations | |
---|---|
GENCON.NS | -0.915 |
DFMFOODS.NS | -0.9 |
JSL.NS | -0.89 |
MBAPL.NS | -0.885 |
SUNFLAG.NS | -0.875 |
MAGNUM.NS | -0.873 |
TOUCHWOOD.NS | -0.857 |
ACI.NS | -0.856 |
GTNIND.NS | -0.854 |
RAJRILTD.NS | -0.853 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gland Pharma Limited Correlation - Currency/Commodity
Gland Pharma Limited Financials
Annual | 2022 |
Revenue: | INR36.25B |
Gross Profit: | INR19.39B (53.50 %) |
EPS: | INR47.44 |
FY | 2022 |
Revenue: | INR36.25B |
Gross Profit: | INR19.39B (53.50 %) |
EPS: | INR47.44 |
FY | 2022 |
Revenue: | INR43.84B |
Gross Profit: | INR22.75B (51.89 %) |
EPS: | INR73.81 |
FY | 2021 |
Revenue: | INR34.24B |
Gross Profit: | INR19.32B (56.42 %) |
EPS: | INR63.07 |
Financial Reports:
No articles found.
Gland Pharma Limited
Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators